Melanoma in situ: Part I. Epidemiology, screening, and clinical features.
about
Estrogen Receptor β in Melanoma: From Molecular Insights to Potential Clinical UtilitySkin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic ApproachesIntercellular crosstalk in human malignant melanoma.Diagnosis and management of lentigo maligna: an observational study comparing 2005 with 2014 data in one institution.Epidemiological trends in skin cancer.Lentigo maligna melanoma with a history of cosmetic treatment: Prevalence, surgical outcomes and considerations.Vitamin E δ-tocotrienol triggers endoplasmic reticulum stress-mediated apoptosis in human melanoma cells.Gender-Based Differences and Barriers in Skin Protection Behaviors in Melanoma SurvivorsDermoscopy in the era of dermato-oncology: from bed to bench side and retour.Hormonal Regulation of the Repair of UV Photoproducts in Melanocytes by the Melanocortin Signaling Axis.Variation among pathologists' treatment suggestions for melanocytic lesions: A survey of pathologists.Amelanotic Lentigo Maligna Melanoma: Mohs Surgery as the Definitive Treatment of an Invisible Tumour.Diagnosis of an additional in situ melanoma does not influence survival for patients with a single invasive melanoma: A registry-based follow-up study.Linear Malignant Melanoma In Situ: Reports and Review of Cutaneous Malignancies Presenting as Linear Skin Cancer.BRAF-V600 mutational status affects recurrence patterns of melanoma brain metastasis.Andrographolide inhibits proliferation and induces cell cycle arrest and apoptosis in human melanoma cells.
P2860
Q28078465-F3150F3D-EF97-43EC-9DFE-88232039C854Q30238649-E012E168-4965-4FA9-9308-8BA5630EBBC0Q30241921-9D8004D5-C0F5-45B4-8CFD-EB0FE2CBA121Q31164770-A1A7E043-D21A-4DD3-9D9F-6C8AB509AE74Q33655972-5EC6C99C-3489-4414-8CD9-56B57FC5BB47Q36384396-D706D6FF-05DA-49E9-A5FA-7EACB9DDF2CAQ37200271-560322F0-48F1-4CE1-89BB-66FA1ED17721Q37239624-86B3D88F-51E0-4E44-BF18-C914EF2BF7BFQ38783355-7FA45AFF-2E5E-415E-8C48-9D6C7FA46656Q38958919-E007A5AF-3E72-4126-8359-0C8983CFB567Q39332702-AD21DAD0-FA77-4B41-8107-765D6F9AFD4FQ39420175-C68640F8-473B-4D62-806D-AB37F1A5DBE4Q40971196-7F39EB78-5B21-4223-ACD5-88C91611B234Q46208221-C537292D-0F82-4DAC-A727-7AC8EB86E407Q48656930-683B8CB5-3ACD-4A1C-9E4A-E4E462AE8259Q52649711-86FD761F-3B93-494D-A249-87EFE807C639
P2860
Melanoma in situ: Part I. Epidemiology, screening, and clinical features.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Melanoma in situ: Part I. Epidemiology, screening, and clinical features.
@en
type
label
Melanoma in situ: Part I. Epidemiology, screening, and clinical features.
@en
prefLabel
Melanoma in situ: Part I. Epidemiology, screening, and clinical features.
@en
P2093
P1476
Melanoma in situ: Part I. Epidemiology, screening, and clinical features.
@en
P2093
Anjela Galan
David J Leffell
H William Higgins
Kachiu C Lee
P304
181-90, quiz 191-2
P356
10.1016/J.JAAD.2015.04.014
P407
P577
2015-08-01T00:00:00Z